Role of p53-dependent placental apoptosis in the reproductive and developmental toxicities of caffeine in rodents

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 4, 2012, Pages 357-363

  Huang, Jing ^a   Zhou, Shu ^a   Ping, Jie ^a   Pan, Xiaoliang ^a,b   Liang, Gai ^a   Xu, Dan ^a,b   Kou, Hao ^a,b   Bao, Chong ^a   Wang, Hui ^a,b  

^a WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Caffeine; Intrauterine growth retardation; Placental apoptosis; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; APOPTOSIS REGULATORY PROTEIN; CAFFEINE; PROLACTIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONCEPTION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS WEIGHT; GESTATIONAL AGE; INTRAUTERINE GROWTH RETARDATION; MOUSE; NONHUMAN; PLACENTA; PLACENTA WEIGHT; PREGNANCY; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPRODUCTION; RODENT; WEIGHT GAIN;

ANIMALS; APOPTOSIS; CAFFEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FERTILIZATION; FETAL DEVELOPMENT; MICE; PLACENTA; PREGNANCY; RANDOM ALLOCATION; RATS; RATS, WISTAR; REPRODUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84858970171     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2012.05676.x     Document Type: Article

References (35)

1. Barone JJ, Roberts HR. Caffeine consumption. Food Chem. Toxicol. 1996; 34: 119-29.
2. Kuczkowski KM. Caffeine in pregnancy. Arch. Gynecol. Obstet. 2009; 280: 695-8.
3. Bolúmar F, Olsen J, Rebagliato M, Bisanti L. Caffeine intake and delayed conception: A European multicenter study on infertility and subfecundity. European Study Group on Infertility Subfecundity. Am. J. Epidemiol. 1997; 145: 324-34.
4. Valsamakis G, Kanaka-Gantenbein C, Malamitsi-Puchner A, Mastorakos G. Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome. Ann. NY Acad. Sci. 2006; 1092: 138-47.
5. Fernandes O, Sabharwal M, Smiley T, Pastuszak A, Koren G, Einarson T. Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: A meta-analysis. Reprod. Toxicol. 1998; 12: 435-44.
6. Chatelain P. Children born with intrauterine growth retardation (IUGR) or small for gestational age (SGA): Long term growth and metabolic consequences. Endocr. Regul. 2000; 34: 33-6.
7. Rengasamy P, Shafiullah M, Sarabjit S. Beneficial effect of supplemental lipoic acid on diabetes-induced pregnancy loss in the mouse. Ann. NY Acad. Sci. 2006; 1084: 118-31.
8. Engelbregt MJ, van Weissenbruch MM, Popp-Snijders C, Lips P, Delemarre-van de Waal HA. Body mass index, body composition, and leptin at onset of puberty in male and female rats after intrauterine growth retardation and after early postnatal food restriction. Pediatr. Res. 2001; 50: 474-8.
9. Gluckman PD, Harding JE. The physiology and pathophysiology of intrauterine growth retardation. Horm. Res. 1997; 48: 11-16.
10. Gilbert WM, Danielsen B. Pregnancy outcomes associated with intrauterine growth restriction. Am. J. Obstet. Gynecol. 2003; 188: 1596-9.
11. de Onis M, Blossner M, Villar J. Levels and patterns of intrauterine growth retardation in developing countries. Eur. J. Clin. Nutr. 1998; 52(Suppl. 1): S5-15.
12. Cox P, Marton T. Pathological assessment of intrauterine growth restriction. Best Pract. Res. Clin. Obstet. Gynaecol. 2009; 23: 751-64.
13. Foidart JM, Seak-San S, Emonts P, Schaaps JP. Vascular placental pathology in high-risk groups: Definition and synopsis. Ann. Med. Interne. (Paris) 2003; 154: 332-9.
14. 1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants. J. Clin. Invest. 1998; 101: 442-54.
15. Kossmehl P, Kurth E, Faramarzi S et al. Mechanisms of apoptosis after ischemia and reperfusion: Role of the renin-angiotensin system. Apoptosis 2006; 11: 347-58.
16. Leri A, Claudio P, Li Q et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J. Clin. Invest. 1998; 101: 1326-42.
17. Bu YZ, Li XY, Zhang BJ, Chung IK, Lee JA. Microcystins cause embryonic toxicity in mice. Toxicon 2006; 48: 966-72.
18. Patil RD, Dwivedi P, Sharma AK. Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats. Reprod. Toxicol. 2006; 22: 679-87.
19. Rohr LR, Layfield LJ, Wallin D, Hardy D. A comparison of routine and rapid microwave tissue processing in a surgical pathology laboratory. Am. J. Clin. Pathol. 2001; 115: 703-8.
20. Su P, Zhang L, Peng Y, Liang A, Du K, Huang D. A histological and ultrastructural study of femoral head cartilage in a new Type II collagenopathy. Int. Orthop. 2010; 34: 1333-9.
21. Martin MM, White CR, Li H, Miller PJ, Elton TS. A functional comparison of the rat type-1 angiotensin II receptors (AT1AR and AT1BR). Regul. Pept. 1995; 60: 135-47.
22. Kakar SS, Sellcrs JC, Devor DC, Musgrove LC, Neill JD. Angiotensin II type-I receptor cDNAs: Differential tissue expression and hormonal regulation. Biochem. Biophys. Res. Commun. 1992; 183: 1090-6.
23. 1 receptor in rat lung microvascular endothelial cell. J. Surg. Res. 2006; 134: 190-7.
24. Salafia CM, Charles AK, Maas EM. Placenta and fetal growth restriction. Clin. Obstet. Gynecol. 2006; 49: 236-56.
25. Saxena BN, Emerson K Jr, Selenkow HA. Serum placental lactogen (HPL) levels as an index of placental function. N. Engl. J. Med. 1969; 281: 225-31.
26. Cobellis L, De Falco M, Torella M et al. Modulation of Bax expression in physiological and pathological human placentas throughout pregnancy. In Vivo 2007; 21: 777-83.
27. Nomura K, Saito S, Ide K et al. Caffeine suppresses the expression of the Bcl-2 mRNA in BeWo cell culture and rat placenta. J. Nutr. Biochem. 2004; 15: 342-9.
28. Qiao S, Nagasaka T, Harada T, Nakashima N. p53, Bax and Bcl-2 expression, and apoptosis in gestational trophoblast of complete hydatidiform mole. Placenta 1998; 19: 361-9.
29. 1 receptor by progesterone in human placenta. J. Clin. Endocrinol. Metab. 1996; 81: 998-1002.
30. Nielsen AH, Schauser KH, Poulsen K. Current topic: The uteroplacental renin-angiotensin system. Placenta 2000; 21: 468-77.
31. Leaney JL, Tinker A. The role of members of the pertussis toxin-sensitive family of G proteins in coupling receptors to the activation of the G protein-gated inwardly rectifying potassium channel. Proc. Natl Acad. Sci. USA 2000; 97: 5651-6.
32. Tofovic SP, Kusaka H, Rominski B, Jackson EK. Caffeine increases renal renin secretion in a rat model of genetic heart failure. J. Cardiovasc. Pharmacol. 1999; 33: 440-50.
33. Miura S, Karnik SS. Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. EMBO J. 2000; 19: 4026-35.
34. Wang Y. Basic knowledge of functional experiment. In: Hu HZ (ed.). Medical Functional Experimental Tutoria. Science Press, Beijing. 2005; Ch. 2 (in Chinese).
35. Butt MS, Sultan MT. Coffee and its consumption: Benefits and risks. Crit. Rev. Food Sci. Nutr. 2011; 51: 363-73.